Crossmark

Intensity-modulated radiation therapy can reduce acute toxicities in long-course neoadjuvant radiation therapy combined with S-1 for locally advanced rectal cancer

Crossref DOI link: https://doi.org/10.1007/s10147-024-02690-1

Published Online: 2025-01-15

Published Print: 2025-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tatsuno, Saori

Doi, Hiroshi https://orcid.org/0000-0003-3237-2119
Inada, Masahiro

Fukuda, Junki

Ishida, Naoko

Uehara, Takuya

Nakamatsu, Kiyoshi

Hosono, Makoto

Kawamura, Junichiro

Matsuo, Yukinori
Funding

Funding for this research was provided by:

Japan Society for the Promotion of Science (22K07733)
License Information

Text and Data Mining valid from 2025-01-15

Version of Record valid from 2025-01-15
More Information

Article History

Received: 4 September 2024

Accepted: 30 December 2024

First Online: 15 January 2025

Declarations

:

: The authors have no conflict of interest to declare.

: This study was conducted according to the guidelines of the Declaration of Helsinki. This study was approved by our institutional review board with approval number R05-153.

: Written informed consent for radiotherapy was obtained from all individual participants prior to radiotherapy. Informed consent for this study was obtained in the form of opt-out.

Document is current

Any future updates will be listed below